Relevium Technologies Signs LOI to Acquire a Controlling Interest in a Montreal-Based Distribution Company
Relevium Technologies Signs LOI to Acquire a Controlling Interest in a Montreal-Based Distributuon Company
– Momentum Public Relations –
Press Release: May 19, 2016
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) is pleased to announce it has executed a letter of intent to acquire a controlling interest and progressively 100{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of a Montreal-based B2B distribution and D2C E-retail company that specializes on high quality exclusive performance products and technologies for North America.
The acquisition target is a growing distribution and D2C company with an existing revenue base of over $500,000.00 CAD through a narrow and focused number of products, which are expected to grow organically at a rate of 50{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} per year. The acquisition target is currently in the process of negotiating the expansion of its product offering and is anticipating introducing several new SKUs, all of which are expected to translate into significant increase in market reach and revenues. The proposed transaction, the details of which will be disclosed upon execution of a definite agreement, is expected to become Relevium’s main distribution and E-retail capability for new technologies and exclusive products for North America by leveraging its experienced team and established relationships with specialty stores and major retail chains across the US and Canada.
In addition to the current performance products sold by the acquisition target, Relevium also plans to utilize and leverage the new partnership to develop a new platform for launching, distributing and retailing connected sports performance products, specialized nutritional supplements, innovative pain management devices and recovery products, all in line with the Company’s overall strategy. The addition of the new products and technologies as well as the addition of E-retail capabilities are estimated to materially increase revenues and as well as branding strength of the Company.
Leena Lakdawala, CEO of Relevium Technologies stated: “As part of our growth strategy, this partnership is expected to provide Relevium access to an established and growing network of performance and wellness retailers both in Canada and the US. The proposed target counts with an experienced team who truly understands the role of relationship and trust-based selling, both of which represent the basis for a successful distribution, retail and D2C strategy”
The transaction is expected to close within the next 30 days and is subject to customary due diligence, market compliance and financing.
About Relevium Technologies Inc.
Relevium is a TSXV listed company (TSX VENTURE:RLV) focused on growth through the acquisition of businesses, products and/or technologies within the scope of the expanding health and wellness sector, specifically under three important verticals: Pain Relief, Recovery andPerformance. Relevium currently holds patented intellectual property for application of static magnetic fields on direct-to-consumer devices, which aid in decreasing pain, improving recovery time and enhancing overall physical performance.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
“Leena Lakdawala”
CEO and Director
Learn more by clicking here: www.releviumtechnologies.com
- Published in Bio technology, Life Sciences, News Home, Nutraceutical, Relevium Technologies
Relevium Technologies Returns 8,612,500 Shares to Treasury
Relevium Technologies Returns 8,612,500 Shares to Treasury
– Momentum Public Relations –
Press Release: April 22, 2016
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) is pleased to announce it has received approval from the TSX Venture Exchange (the “Exchange”) regarding the cancellation of 8,612,500 previously issued shares relating to the acquisition of the assets of BIOflex Medical Magnetics, Inc. (the “Qualifying Transaction”) leaving the Company with a total of 29,525,966 common shares outstanding.
Leena Lakdawala, CEO of Relevium stated: “Management has been working diligently to create value for our shareholders. We have just returned over 8.5 million shares to the Company’s treasury, reducing the outstanding shares to fewer than 30 million and effectively cutting the cost of the BIOflex acquisition down by 50{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce}. Relevium has recently executed an Exclusive Supply Agreement for our patented magnetic technology with Back-A-Line Inc., a California-based leader in back pain solutions, and the Company remains actively engaged in identifying additional assets within the growing global health and wellness market.”
Pursuant to Relevium’s news release dated February 29, 2016, the Company, BIOflex and iTech Medical, Inc. have agreed to adjust the purchase price under the Purchase Agreement (the “Purchase Price Adjustment”). As part of, and in satisfaction of, the Purchase Price Adjustment: (i) BIOflex shall return a total of 8,612,500 common shares in the capital of the Company which it currently owns to the Company for cancellation; (ii) the Company shall issue 1,722,500 common share purchase warrants to BIOflex (which shall be restricted and legended pursuant to applicable Canadian and U.S. securities laws), with each warrant being exercisable to acquire one common share in the capital of the Company, at a price of $0.1125 per share (being the same issue price as the securities transacted pursuant the Qualifying Transaction and representing a premium to the current market price of the Company’s common shares on the TSX Venture Exchange), for a period of three years from the date of issuance of the warrants; and (iii) the Company shall release the right of first refusal in respect of the muscle pattern recognition (MPR) technology of iTech Medical, Inc.
In addition, and as part of the discussions relating to the Purchase Price Adjustment, the Company has determined to settle the $225,000 loan owing from iTech Medical, Inc., as well as any accrued interest thereon. Other than as regards the Purchase Price Adjustment, terms and conditions and the duties and obligations of the parties pursuant to the Purchase Agreement continue in full force and effect.
About Relevium Technologies Inc.
Relevium is a TSXV listed company focused on growth through the acquisition of businesses, products and/or technologies within the scope of the expanding health and wellness sector, specifically under three important verticals: Pain Relief, Recovery and Performance. Relevium currently holds patented intellectual property for application of static magnetic fields on direct-to-consumer devices, which aid in decreasing pain, improving recovery time and enhancing overall physical performance.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Leena Lakdawala, CEO and Director
Learn more by clicking here: www.releviumtechnologies.com
- Published in Bio technology, Life Sciences, News Home, Nutraceutical, Relevium Technologies
Relevium Technologies Provides Corporate Update
Relevium Technologies Provides Corporate Update
– Momentum Public Relations –
Press Release: April 6, 2016
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) is pleased to provide an update regarding the previously announced corporate roll-up strategy, focused on acquiring products, technologies or companies within the rapidly expanding global health and wellness sector.
In addition to undergoing initiatives to commercialize, partner and license its Patented Technology, Relevium has entered into discussions with potential acquisition targets consisting of revenue generating and profitable businesses well aligned with the Company’s strategy and market focus. Management plans to continue to provide progress updates and anticipates it will enter into exclusive discussions with some of these targets during the second quarter of this calendar year.
In addition to products and technologies for Pain, Recovery and Performance, management is also examining opportunities in the delivery of comprehensive wellness services. Management believes that the growth in the wellness sector of the economy will be fueled by Baby Boomers, which represent approximately one third of the U.S. and Canadian population. This is historically the largest, most active and health conscious consumer group entering pre-retirement. This consumer group seeks a balanced and active lifestyle combined with personalized care and unique product offerings, all as viable alternatives to pharmaceutical prescription drugs.
Leena Lakdawala, CEO of Relevium Technologies Inc. stated: “The global health and wellness market is projected to hit record high levels by 2017, and today’s informed consumers are choosing a balanced lifestyle focused on health and wellness. People are staying active longer and eating healthier to avoid disease and medication dependencies. Relevium’s corporate strategy aims at leveraging this growing demand by strategically defining three unique verticals of Pain Relief, Recovery and Performance and offering unique deliverables under one company.”
About Relevium Technologies Inc.
Relevium is a TSXV listed company focused on growth through the acquisition of businesses, products and/or technologies within the scope of the expanding health and wellness sector, specifically under three important verticals: Pain Relief, Recovery and Performance. Relevium Technologies Inc. currently holds patented intellectual property for application of static magnetic fields on direct-to-consumer devices, which aid in decreasing pain, improving recovery time and enhancing overall physical performance.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
“Leena Lakdawala“
CEO and Director
Learn more by clicking here: www.releviumtechnologies.com
- Published in Bio technology, Life Sciences, News Home, Nutraceutical, Relevium Technologies, Technology
Relevium Technologies Enters Into Exclusive Supply Agreement
Relevium Technologies Enters Into Exclusive Supply Agreement
– Momentum Public Relations –
Press Release: April 4, 2016
Relevium Technologies Inc. (TSX VENTURE: RLV) (FRANKFURT: 6BX) is pleased to provide an update on its corporate strategy, which is primarily focused on the acquisition of products or companies within three major verticals in the health and wellness sector: Pain Relief, Recovery and Performance.
Relevium is pleased to announce that it has executed an Exclusive Supply Agreement of its patented magnetic technology with Back-A-Line Inc., a California-based leader in back pain solutions. Relevium will provide its latest patented magnetic field technology for insertion in the company’s Dynamic Back Support system, which combined, will help improve healing and pain management for back related injuries. Back-A-Line sells its Dynamic Back Support across many industries, including air transport, food and grocery, health care, trucking, and manufacturing as well as public sector unions and the US Army.
“We are very excited about this initial cooperation between Relevium and Back-A-Line Inc., and we believe that the combination of their unique patented design and our technology will prove to be a great source of relief to those suffering from back pain” stated Bill Landtbom, CEO of Back-A-Line Inc. He stated further: “This unique combined wearable was devised specifically for chronic back pain, a market of approximately 20M adults in the US alone. In our opinion, no other device and “conservative” protocol can provide the same effective alternative to pharmaceuticals and surgery”.
“We are pleased with this initial partnership and we believe that the passion, dedication and product offering of Back-A-Line is an ideal fit for our technology. The combination of their Dynamic Belt Support product with our patented technology will provide their customers with a unique and effective solution for dealing with back pain and overall wellbeing”, stated Leena Lakdawala, CEO of Relevium Technologies.
The company remains actively engaged in identifying ecommerce assets within its three active verticals and is currently reviewing several candidates that fit well with the Company’s strategy. Additionally, the Company is exploring the opportunity to provide services in this sector.
About Relevium Technologies Inc.
Relevium is a TSXV listed company focused on growth through the acquisition of businesses, products and/or technologies within the scope of the expanding health and wellness sector, specifically under three important verticals: Pain Relief, Recovery and Performance. Relevium Technologies Inc. currently holds patented intellectual property for application of static magnetic fields on direct-to-consumer devices, which aid in decreasing pain, improving recovery time and enhancing overall physical performance.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
“Leena Lakdawala“
CEO and Director
Learn more by clicking here: www.releviumtechnologies.com
- Published in Bio technology, Life Sciences, News Home, Nutraceutical, Relevium Technologies, Technology, Uncategorized
- 1
- 2